Free Research Report as Intuitive Surgical's Revenues Jumped 20%; Non-GAAP EPS Surged 38%

Stock Monitor: NeuroMetrix Post Earnings Reporting

LONDON, UK / ACCESSWIRE / July 25, 2018 / If you want access to our free earnings report on Intuitive Surgical, Inc. (NASDAQ: ISRG), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=ISRG. The Company reported its second quarter fiscal 2018 operating and financial results on July 19, 2018. The robotic surgical systems maker outperformed top- and bottom-line expectations. Additionally, the Company provided its guidance for FY18. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for NeuroMetrix, Inc. (NASDAQ: NURO), which also belongs to the Healthcare sector as the Company Intuitive Surgical. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=NURO

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Intuitive Surgical most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=ISRG

Earnings Highlights and Summary

For the second quarter of the fiscal year 2018, Intuitive Surgical's revenues grew approximately 20% to $909 million compared to $759 million in Q2 2017. The Company's total recurring revenues were $643 million in the reported quarter, representing 71% of the Company's total revenues. Intuitive Surgical's revenue numbers beat analysts' estimates of $876 million.

During Q2 2018, Intuitive Surgical's GAAP income from operations increased to $277 million compared to $260 million in Q2 2017. The Company's GAAP income from operations included a pre-tax litigation charge of $43 million in the reported quarter. Intuitive Surgical's non-GAAP income from operations increased to $389 million in Q2 2018 compared to $315 million in Q2 2017.

For Q2 2018, Intuitive Surgical's GAAP net income was $255 million, or $2.15 per diluted share, compared to $223 million, or $1.94 per diluted share, in Q2 2017. The Company's non-GAAP net income was $327 million, or $2.76 per diluted share, in the reported quarter compared to $230 million, or $2.00 per diluted share, in the prior year's same quarter. Intuitive Surgical's earnings surpassed Wall Street's estimates of $2.50 per share.

Operating Results

During Q2 2018, Intuitive Surgical's worldwide da Vinci procedures grew approximately 18% on a y-o-y basis, driven primarily by a growth in US general surgery procedures and worldwide urologic procedures. The Company shipped 220 da Vinci Surgical Systems in the reported quarter compared to 166 in the year earlier same quarter. Intuitive Surgical's system shipments included 44 systems shipped under operating lease arrangements in Q2 2018 compared to 27 during Q2 2017.

For Q2 2018, Intuitive Surgical's instrument and accessory revenues increased by approximately 20% to $476 million compared to $398 million in Q2 2017, primarily driven by a growth of approximately 18% in da Vinci procedure volume.

Intuitive Surgical's systems revenues increased by approximately 25% to $277 million in Q2 2018 compared to $221 million in Q2 2017. The Company's service revenues increased by approximately 11% to $156 million in the reported quarter versus $140 million in the year earlier comparable quarter.

Cash Matters

Intuitive Surgical ended Q2 2018 with cash, cash equivalents, and investments of $4.3 billion, representing an increase of $191 million, primarily driven by cash generated from operations.

Outlook

Intuitive Surgical raised its forecasts and estimated a procedure growth of 14.5% to 16.5% for the full fiscal year 2018. The Company is expecting pro-forma gross profit margin as a percentage of net revenues to be within a range of 70% and 71.5%.

Stock Performance Snapshot

July 24, 2018 - At Tuesday's closing bell, Intuitive Surgical's stock was marginally up 0.64%, ending the trading session at $523.22.

Volume traded for the day: 924.62 thousand shares, which was above the 3-month average volume of 811.43 thousand shares.

Stock performance in the last month - up 8.28%; previous three-month period - up 19.88%; past twelve-month period - up 65.37%; and year-to-date - up 43.37%

After yesterday's close, Intuitive Surgical's market cap was at $60.56 billion.

Price to Earnings (P/E) ratio was at 53.88.

The stock is part of the Healthcare sector, categorized under the Medical Instruments & Supplies industry. This sector was up 0.4% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsoredand non-sponsored reports, articles, stock market blogs, and popular investmentnewsletters covering equities listed on NYSE and NASDAQ and Canadian stocks.A-I has two distinct and independent departments. One department producesnon-sponsored analyst certified content generally in the form of pressreleases, articles and reports covering equities listed on NYSE and NASDAQ andthe other produces sponsored content (in most cases not reviewed by aregistered analyst), which typically consists of compensated investmentnewsletters, articles and reports covering listed stocks and micro-caps. Suchsponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly orindirectly; for producing or publishing this document.

PRESS RELEASEPROCEDURES:

The non-sponsored content contained herein has beenprepared by a writer (the "Author") and is fact checked and reviewedby a third-party research service company (the "Reviewer")represented by a credentialed financial analyst [for further information onanalyst credentials, please email info@active-investors.com.Rohit Tuli, a CFA^® charterholder (the"Sponsor"), provides necessary guidance in preparing the documenttemplates. The Reviewer has reviewed and revised the content, as necessary,based on publicly available information which is believed to be reliable.Content is researched, written and reviewed on a reasonable-effort basis. TheReviewer has not performed any independent investigations or forensic audits tovalidate the information herein. The Reviewer has only independently reviewedthe information provided by the Author according to the procedures outlined byA-I. A-I is not entitled to veto or interfere in the application of suchprocedures by the third-party research service company to the articles,documents or reports, as the case may be. Unless otherwise noted, any contentoutside of this document has no association with the Author or the Reviewer inany way.

NO WARRANTY

A-I, the Author, and the Reviewer are notresponsible for any error which may be occasioned at the time of printing ofthis document or any error, mistake or shortcoming. No liability is acceptedwhatsoever for any direct, indirect or consequential loss arising from the useof this document. A-I, the Author, and the Reviewer expressly disclaim anyfiduciary responsibility or liability for any consequences, financial orotherwise arising from any reliance placed on the information in this document.Additionally, A-I, the Author, and the Reviewer do not (1) guarantee theaccuracy, timeliness, completeness or correct sequencing of the information, or(2) warrant any results from use of the information. The included informationis subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering,recommendation, or a solicitation of an offer to buy or sell the securitiesmentioned or discussed, and is to be used for informational purposes only.Please read all associated disclosures and disclaimers in full beforeinvesting. Neither A-I nor any party affiliated with us is a registeredinvestment adviser or broker-dealer with any agency or in any jurisdictionwhatsoever. To download our report(s), read our disclosures, or for moreinformation, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach outto us directly. If you're a company we are covering andwish to no longer feature on our coverage list contact us via email and/orphone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com
Phone number: 73 29 92 6381
OfficeAddress: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, WilayahPersekutuan Kuala Lumpur, Malaysia

SOURCE:Active-Investors